华西口腔医学杂志 ›› 2018, Vol. 36 ›› Issue (3): 325-330.doi: 10.7518/hxkq.2018.03.018
收稿日期:
2017-08-11
修回日期:
2017-12-09
出版日期:
2018-06-01
发布日期:
2018-06-01
作者简介:
王迪侃,硕士,E-mail:
基金资助:
Received:
2017-08-11
Revised:
2017-12-09
Online:
2018-06-01
Published:
2018-06-01
Supported by:
摘要:
唾液用于疾病的诊断越来越受到重视,由于口腔癌(OCC)发生部位的特点,唾液中白细胞介素(IL)可作为OCC诊断的生物标志物,并与OCC的发生、发展、侵袭、转移密切相关。本文对唾液中IL的检测方法及其与OCC发生、发展的关系等方面的研究进展进行综述。
中图分类号:
王迪侃, 廖贵清. 唾液中白细胞介素与口腔癌的关系[J]. 华西口腔医学杂志, 2018, 36(3): 325-330.
Dikan Wang, Guiqing Liao. Relationship between interleukins in the saliva and oral cavity cancer[J]. West China Journal of Stomatology, 2018, 36(3): 325-330.
表 1
不同人群唾液中IL浓度的比较
项目 | 检测方法 | 正常人群 | 癌前状态 | 口腔癌 | 统计结果 |
---|---|---|---|---|---|
IL-1β | ELISA | 354.00±61.51 | 143.00±54.74 | 906.00±62.21 | *#[ |
Luminex | 376.30±576.3 | ND | 1 013.50±1 221.10 | *[ | |
IL-1Ra | Luminex | 1 949.2±1 178.0 | ND | 2 831.7±2 506.4 | *[ |
IL-6 | ELISA | 9.68±12.838 | 43.00±52.143 | 132.88±59.098 | *#ǂ[ |
ELISA | 4.61±4.42 | 14.93±16.48 | ND | ǂ[ | |
ELISA | 1.4±0.9 | 70.8±24.3 | 88.2±43.2 | *#ǂ[ | |
ELISA | 16.00±3.91 | 18.00±5.19 | 129.00±66.59 | *#[ | |
IL-8 | ELISA | 1 580.0±789.0 | 1 918.2±899.1 | 3 154.1±1 023.2 | *#ǂ[ |
ELISA | 210.0±142.3 | 299.5±158.2 | 1 718.6±668.3 | *#[ | |
ELISA | 349.6±115.1 | 650.4±207.3 | 1 091.7±167.1 | *#ǂ[ | |
Luminex | 947.3±2 036.8 | ND | 2 834.9±3 385.6 | *[ | |
IL-10 | Luminex | 1.72±1.33 | ND | 4.45±4.29 | *[ |
IL-13 | Luminex | 0.23±0.19 | ND | 0.76±0.57 | *[ |
IL-18 | ELISA | 12.29±5.11 | 20.12±5.78 | ND | ǂ[ |
[1] | Brailo V, Vucicevic-Boras V, Lukac J, et al.Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer[J]. Med Oral Patol Oral Cir Bucal, 2012: e10-e15. |
[2] | Rajkumar K, Nandhini G, Ramya R, et al.Validation of the diagnostic utility of salivary interleukin 8 in the differen-tiation of potentially malignant oral lesions and oral squa-mous cell carcinoma in a region with high endemicity[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2014, 118(3): 309-319. |
[3] | Rhodus NL, Ho V, Miller CS, et al.NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma[J]. Cancer Detect Prev, 2005, 29(1): 42-45. |
[4] | Liu J, Duan Y.Saliva: a potential media for disease diag-nostics and monitoring[J]. Oral Oncol, 2012, 48(7): 569-577. |
[5] | Panneer Selvam N, Sadaksharam J.Salivary interleukin-6 in the detection of oral cancer and precancer[J]. Asia Pac J Clin Oncol, 2015, 11(3): 236-241. |
[6] | Arellano-Garcia M, Hu S, Wang J, et al.Multiplexed im-munobead-based assay for detection of oral cancer protein biomarkers in saliva[J]. Oral Dis, 2008, 14(8): 705-712. |
[7] | Malhotra R, Patel V, Chikkaveeraiah BV, et al.Ultrasensi-tive detection of cancer biomarkers in the clinic by use of a nanostructured microfluidic array[J]. Anal Chem, 2012, 84(14): 6249-6255. |
[8] | Torrente-Rodríguez RM, Campuzano S, Ruiz-Valdepeñas Montiel V, et ala. Electrochemical bioplatforms for the simul-taneous determination of interleukin (IL)-8 mRNA and IL-8 protein oral cancer biomarkers in raw saliva[J]. Biosens Bioelectron, 2016, 77: 543-548. |
[9] | Rahnama M, Jastrzębska I, Jamrogiewicz R, et al.IL-1α and IL-1β levels in blood serum and saliva of menopausal women[J]. Endocr Res, 2013, 38(2): 69-76. |
[10] | Kamatani T, Shiogama S, Yoshihama Y, et al.Interleukin-1 beta in unstimulated whole saliva is a potential biomarker for oral squamous cell carcinoma[J]. Cytokine, 2013, 64(2): 497-502. |
[11] | Öngöz Dede F, Balli U, Bozkurt Doğan Ş, et al.Interleukin-32 levels in gingival crevicular fluid and saliva of patients with chronic periodontitis after periodontal treatment[J]. J Perio-dont Res, 2017, 52(3): 397-407. |
[12] | Buduneli N, Özçaka Ö, Nalbantsoy A.Interleukin-33 levels in gingival crevicular fluid, saliva, or plasma do not differ-entiate chronic periodontitis[J]. J Periodontol, 2012, 83(3): 362-368. |
[13] | Köseoğlu S, Sağlam M, Pekbağrıyanık T, et al.Level of interleukin-35 in gingival crevicular fluid, saliva, and plasma in periodontal disease and health[J]. J Periodontol, 2015, 86(8): 964-971. |
[14] | Simcić D, Pezelj-Ribarić S, Grzić R, et al.Detection of sali-vary interleukin 2 and interleukin 6 in patients with burning mouth syndrome[J]. Mediators Inflamm, 2006, 2006(1): 54632. |
[15] | Cogulu D, Onay H, Ozdemir Y, et al.Associations of inter-leukin (IL)-1β, IL-1 receptor antagonist, and IL-10 with dental caries[J]. J Oral Sci, 2015, 57(1): 31-36. |
[16] | St John MA, Li Y, Zhou X, et al.Interleukin 6 and interleu-kin 8 as potential biomarkers for oral cavity and oropharyn-geal squamous cell carcinoma[J]. Arch Otolaryngol Head Neck Surg, 2004, 130(8): 929-935. |
[17] | Aziz S, Ahmed SS, Ali A, et al.Salivary immunosuppressive cytokines IL-10 and IL-13 are significantly elevated in oral squamous cell carcinoma patients[J]. Cancer Invest, 2015, 33(7): 318-328. |
[18] | Brailo V, Vucićević-Boras V, Cekić-Arambasin A, et al.The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia[J]. Oral Oncol, 2006, 42(4): 370-373. |
[19] | Punyani SR, Sathawane RS.Salivary level of interleukin-8 in oral precancer and oral squamous cell carcinoma[J]. Clin Oral Investig, 2013, 17(2): 517-524. |
[20] | Zhang Y, Liu W, Zhang S, et al.Salivary and serum inter-leukin-18 in patients with oral lichen planus: a study in an ethnic Chinese population[J]. Inflammation, 2012, 35(2): 399-404. |
[21] | Lee CH, Syu SH, Liu KJ, et al.Interleukin-1 beta transac-tivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer[J]. Oncotarget, 2015, 6(36): 38866-38880. |
[22] | Lee CH, Chang JS, Syu SH, et al.IL-1β promotes malignant transformation and tumor aggressiveness in oral cancer[J]. J Cell Physiol, 2015, 230(4): 875-884. |
[23] | Sato J, Ohuchi M, Abe K, et al.Correlation between salivary interleukin-6 levels and early locoregional recurrence in patients with oral squamous cell carcinoma: preliminary study[J]. Head Neck, 2013, 35(6): 889-894. |
[24] | Gasche JA, Hoffmann J, Boland CR, et al.Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells[J]. Int J Cancer, 2011, 129(5): 1053-1063. |
[25] | Yu H, Lee H, Herrmann A, et al.Revisiting STAT3 signalling in cancer: new and unexpected biological functions[J]. Nat Rev Cancer, 2014, 14(11): 736-746. |
[26] | Huang JS, Yao CJ, Chuang SE, et al.Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction[J]. BMC Can-cer, 2016, 16: 245. |
[27] | Teruel A, Romero M, Cacalano NA, et al.Potential contri-bution of naïve immune effectors to oral tumor resistance: role in synergistic induction of VEGF, IL-6, and IL-8 secre-tion[J]. Cancer Immunol Immunother, 2008, 57(3): 359-366. |
[28] | Okamoto M, Hiura K, Ohe G, et al.Mechanism for bone invasion of oral cancer cells mediated by interleukin-6 in vitro and in vivo[J]. Cancer, 2000, 89(9): 1966-1975. |
[29] | Shinriki S, Jono H, Ueda M, et al.Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carci-noma[J]. J Pathol, 2011, 225(1): 142-150. |
[30] | Zarogoulidis P, Katsikogianni F, Tsiouda T, et al.Interleu-kin-8 and interleukin-17 for cancer[J]. Cancer Invest, 2014, 32(5): 197-205. |
[31] | Long X, Ye Y, Zhang L, et al.IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways[J]. Int J Oncol, 2016, 48(1): 5-12. |
[32] | Watanabe H, Iwase M, Ohashi M, et al.Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines[J]. Oral Oncol, 2002, 38(7): 670-679. |
[33] | Glogauer JE, Sun CX, Bradley G, et al.Neutrophils increase oral squamous cell carcinoma invasion through an invado-podia-dependent pathway[J]. Cancer Immunol Res, 2015, 3(11): 1218-1226. |
[34] | Peng HY, Jiang SS, Hsiao JR, et al.IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma[J]. Mol Oncol, 2016, 10(6): 895-909. |
[35] | Li X, Fan Q, Li J, et al.MiR-124 down-regulation is critical for cancer associated fibroblasts-enhanced tumor growth of oral carcinoma[J]. Exp Cell Res, 2017, 351(1): 100-108. |
[36] | Moore KW, de Waal Malefyt R, Coffman RL, et al. Inter-leukin-10 and the interleukin-10 receptor[J]. Annu Rev Im-munol, 2001, 19: 683-765. |
[37] | Zhou X, Su YX, Lao XM, et al.CD19+IL-10+ regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4+ T cells to CD4+Foxp3+ regulatory T cells[J]. Oral Oncol, 2016, 53: 27-35. |
[38] | Chen CJ, Sung WW, Su TC, et al.High expression of in-terleukin 10 might predict poor prognosis in early stage oral squamous cell carcinoma patients[J]. Clin Chim Acta, 2013, 415: 25-30. |
[39] | Chandler SW, Rassekh CH, Rodman SM, et al.Immunohis-tochemical localization of interleukin-10 in human oral and pharyngeal carcinomas[J]. Laryngoscope, 2002, 112(5): 808-815. |
[40] | Costa NL, Valadares MC, Souza PP, et al.Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma[J]. Oral Oncol, 2013, 49(3): 216-223. |
[41] | Hsu HJ, Yang YH, Shieh TY, et al.TGF-β1 and IL-10 single nucleotide polymorphisms as risk factors for oral cancer in Taiwanese[J]. Kaohsiung J Med Sci, 2015, 31(3): 123-129. |
[42] | Singh PK, Chandra G, Bogra J, et al.Association of genetic polymorphism in the interleukin-8 gene with risk of oral cancer and its correlation with pain[J]. Biochem Genet, 2016, 54(1): 95-106. |
[43] | Vairaktaris E, Yapijakis C, Serefoglou Z, et al.Gene expres-sion polymorphisms of interleukins-1β, -4, -6, -8, -10, and tumor necrosis factors-α, -β: regression analysis of their effect upon oral squamous cell carcinoma[J]. J Cancer Res Clin Oncol, 2008,134(8): 821-832. |
[44] | Hwang YS, Lee SK, Park KK, et al.Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorp-tion[J]. Oral Oncol, 2012, 48(1): 40-48. |
[45] | Cvikl B, Lussi A, Moritz A, et al.Sterile-filtered saliva is a strong inducer of IL-6 and IL-8 in oral fibroblasts[J]. Clin Oral Investig, 2015, 19(2): 385-399. |
[46] | Sato J, Goto J, Murata T, et al.Changes in saliva interleukin-6 levels in patients with oral squamous cell carcinoma[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2010, 110 |
(3): 330-336. | |
[47] | Thomas GR, Chen Z, Enamorado I, et al.IL-12- and IL-2-induced tumor regression in a new murine model of oral squamous-cell carcinoma is promoted by expression of the CD80 co-stimulatory molecule and interferon-gamma[J]. Int J Cancer, 2000, 86(3): 368-374. |
[48] | Lippitz BE.Cytokine patterns in patients with cancer: a sys-tematic review[J]. Lancet Oncol, 2013, 14(6): e218-e228. |
[1] | 汤盟, 崔占琴, 王阳阳, 陈增国, 李文静, 张翠萍. 低能量激光对人牙周膜细胞白细胞介素-6、肿瘤坏死因子-α、骨保护素、核因子-κB受体活化因子配体表达的影响[J]. 华西口腔医学杂志, 2023, 41(5): 521-532. |
[2] | 侯亚丽, 李荷香, 宋鹏, 杨艳霄, 郝亚丽, 刘慧娟. 肿瘤间质成纤维细胞对体外培养唾液腺多形性腺瘤细胞生物学行为的影响[J]. 华西口腔医学杂志, 2023, 41(2): 149-156. |
[3] | 奚悦, 马玉婷, 姚志刚, 覃业军, 赵苗青. Warthin瘤合并T淋巴母细胞淋巴瘤1例[J]. 华西口腔医学杂志, 2022, 40(6): 727-730. |
[4] | 骆厚卓, 方世殊, 刘倩, 党薇, 王艳丽. 无托槽隐形矫治患者与固定矫治患者龈沟液中白细胞介素变化的对比研究[J]. 华西口腔医学杂志, 2022, 40(3): 293-296. |
[5] | 陈娇, 吕蝶, 陈红利, 张平. 蛋白激酶D抑制剂CRT0066101对唾液腺腺样囊性癌细胞迁移能力的影响[J]. 华西口腔医学杂志, 2022, 40(3): 320-327. |
[6] | 卢倩, 郭柳媚, 毕小琴. 口腔癌患者术后吞咽障碍危险因素的系统评价[J]. 华西口腔医学杂志, 2022, 40(3): 328-334. |
[7] | 魏卓, 周昊, 费伟, 聂雄, 李明芳. SOX2基因对唾液腺腺样囊性癌细胞生物学特性的影响[J]. 华西口腔医学杂志, 2022, 40(3): 341-349. |
[8] | 李若焓, 黄颖昭, 廖乃麟, 吴沉洲, 李一. 口腔癌细胞通过传递性内质网应激影响胰岛β细胞功能的初探[J]. 华西口腔医学杂志, 2022, 40(1): 22-31. |
[9] | 张颖, 贾松菠, 李帆, 李姗姗, 张利娟, 谭凯璇, 卢洁, 杨芳. 低龄儿童龋病相关的唾液生化指标研究[J]. 华西口腔医学杂志, 2021, 39(3): 300-305. |
[10] | 贾美娥, 李志勇, 徐凯, 王怡衡, 于菲, 何祥一. 口腔癌细胞Cal27外泌体对人正常牙龈成纤维细胞的生物学作用[J]. 华西口腔医学杂志, 2021, 39(3): 313-319. |
[11] | 王璐瑶, 汪波, 丛蓓蓓, 崔涛, 杜雨晴, 宋宇. 不同正畸力对大鼠牙周组织压力侧辅助性T细胞17相关因子表达变化的影响[J]. 华西口腔医学杂志, 2021, 39(2): 143-152. |
[12] | 刘伟, 李春洁, 李龙江. 口腔癌颌骨侵犯的分子机制研究进展[J]. 华西口腔医学杂志, 2021, 39(2): 221-226. |
[13] | 李审绥, 吴沉洲, 乔翔鹤, 李春洁, 李龙江. 辐射损伤唾液腺机制及治疗的研究进展[J]. 华西口腔医学杂志, 2021, 39(1): 99-104. |
[14] | 张东升, 郑家伟, 张陈平, 蔡志刚, 李龙江, 廖贵清, 尚政军, 孙沫逸, 韩正学, 尚伟, 孟箭, 龚忠诚, 黄圣运. 口腔癌合并全身系统性疾病患者的多学科协作诊疗模式专家共识[J]. 华西口腔医学杂志, 2020, 38(6): 603-615. |
[15] | 赖静, 白远亮, 柏银, 梅杰, 张芷玮, 唐雯静, 黄姣. 牙周基础治疗对慢性肾病伴牙周炎患者炎症因子影响的Meta分析[J]. 华西口腔医学杂志, 2020, 38(6): 672-680. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||